Current Firm
Lux Capital
Investments
5+ companies
Focus
AI, Biotech
Peter co-founded Lux Capital during the dot-com crash to specifically back deep science and physical-world breakthroughs like nuclear waste remediation and advanced materials, deliberately avoiding software plays to focus on matter that matters. He personally conceived and built several portfolio companies from scratch around long-range theses, including Kurion in nuclear waste and Variant Bio in rare genetics, actively assembling the scientific teams and capital rather than simply backing existing founders.